Revascularização miocárdica e restauração ventricular por meio da pacopexia
OBJECTIVE: To analyze left ventricle performance after myocardial revascularization associated to ventricular geometrics restoration by pacopexy in schemic myocardiopathy patients with significant ventricular dysfunction in whom ventricular restoration was obtained through special technique. METHODS...
| Autores: | , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2007 |
| País: | Brasil |
| Institución: | Universidade Federal de São Paulo (UNIFESP) |
| Repositorio: | Repositório Institucional da UNIFESP |
| Idioma: | portugués |
| OAI Identifier: | oai:repositorio.unifesp.br:11600/3498 |
| Acceso en línea: | http://dx.doi.org/10.1590/S0066-782X2007000200007 http://repositorio.unifesp.br/handle/11600/3498 |
| Access Level: | acceso abierto |
| Palabra clave: | Heart failure congestive myocardial revascularization ventricular function left Insuficiência cardíaca congestiva revascularização miocárdica função ventricular esquerda |
| Sumario: | OBJECTIVE: To analyze left ventricle performance after myocardial revascularization associated to ventricular geometrics restoration by pacopexy in schemic myocardiopathy patients with significant ventricular dysfunction in whom ventricular restoration was obtained through special technique. METHODS: Myocardial revascularization associated to ventricular geometrics restoration through special technique, with no use of prosthesis or other synthetic materials. RESULTS: Patients functional class was shown to have improved 93.10% after surgical procedure. Pre- and post-surgical comparison showed significant increase in left ventricle ejection fraction as well as decrease in left ventricle systolic diameter. No significant change was observed in left ventricle diastolic diameter or systolic volume. Post-surgical follow-up time length ranged from 1 month to 3 years and 4 months. CONCLUSION: Ventricular dysfunction restoration technique through pacopexy showed to be effective for the management of severe ventricular dysfunction from schemic causes. Major impact was observed in the functional class of patients under study. |
|---|